(2026). Fexuprazan for upper gastrointestinal protection in patients with ischemic stroke and gastroesophageal reflux disease (GERD) receiving antithrombotic therapy: A preliminary prospective single-arm observational Study. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Fexuprazan for Upper Gastrointestinal Protection in Patients with Ischemic Stroke and Gastroesophageal Reflux Disease (GERD) Receiving Antithrombotic Therapy: A Preliminary Prospective Single-arm Observational Study."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Fexuprazan for Upper Gastrointestinal Protection in Patients with Ischemic Stroke and Gastroesophageal Reflux Disease (GERD) Receiving Antithrombotic Therapy: A Preliminary Prospective Single-arm Observational Study."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.